Phase 3 biotech developing therapies for autoimmune and inflammatory diseases.
Industry: Health Care
Latest Trade: $12.00 0.00 (0.0%)
First Day Return: +6.8%
Return from IPO: -29.4%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 08/22/2024 |
Offer Price | $17.00 |
Price Range $16.00 - $18.00 | |
Offer Shares (mm) | 13.2 |
Deal Size ($mm) | $225 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 09/12/2024 |
Offer Price | $17.00 |
Price Range $16.00 - $18.00 | |
Offer Shares (mm) | 13.2 |
Deal Size ($mm) | $225 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
Morgan Stanley |
Jefferies |
more |
Company Data | |
---|---|
Headquarters | Waltham, MA, United States |
Founded | 2019 |
Employees at IPO | 114 |
Website www.zenasbio.com |